INTS · Intensity Therapeutics, Inc.
$3.96
-0.04 (-1.00%)
At close · Aug 14
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our balances in cash and cash equivalents, our ability to continue our operations is dependent on obtaining additional capital, which is not within our control. As a result, we believe there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$12.93M
Shares
3.26M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding INTS
5 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | — | 16,841 | $99,025 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 13,588 | $59,651 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 3,245 | $14,246 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 3,092 | $13,574 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 276 | $1,212 | 0.00% | Long | 2026-05-31 |
Showing 1–5 of 5 positions
Key facts
CIK
1567264
CUSIP
45828J202
13F (30d)
15 filings
15 filers
Visit website
Investor relations